Finance

Lists
METROPOLIS:NSE
Metropolis Healthcare Ltd
518,00 INR
-1,41%
(-7,40) 1D
15-окт., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for METROPOLIS...
Open
526,90 INR
High
548,95 INR
Low
517,00 INR
Mkt. cap
107,46 млд
Avg. vol.
232,87 миң
Volume
248,41 миң
Dividend
0,58%
Quarterly dividend
0,75 INR
Ex-dividend date
2026-ж., 19-май
P/E ratio
53,35
52-wk high
609,05 INR
52-wk low
412,25 INR
EPS
9,71 INR
No. of employees
4 миң
Open
526,90 INR
High
548,95 INR
Low
517,00 INR
Mkt. cap
107,46 млд
Avg. vol.
232,87 миң
Volume
248,41 миң
Dividend
0,58%
Quarterly dividend
0,75 INR
Ex-dividend date
2026-ж., 19-май
P/E ratio
53,35
52-wk high
609,05 INR
52-wk low
412,25 INR
EPS
9,71 INR
No. of employees
4 миң
News stories
From web sources and news partners
Profile
Metropolis Healthcare, also known as Metropolis Labs, is an Indian multinational chain of diagnostic labs, with its central laboratory in Mumbai, Maharashtra. Metropolis Healthcare has a chain of 124 clinical laboratories and 2400 collection centers across 7 countries including India. The healthcare company was founded in 1980. The company went public in April 2019. Wikipedia
About Metropolis Healthcare Ltd
CEOVijender Singh
Employees4,48 миң
Founded1980
Headquarters-
SectorHealth care provider
Last report
2026-ж., 5-авг.
Fiscal period
Q1 2027
2,73 INR / 2,65 INR
+3,07%beat
Revenue / Est. (INR)
4,50 млд / 4,46 млд
+0,93%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
4,29 млд
4,06 млд
4,25 млд
4,50 млд
Cost of goods sold
877,48 млн
792,37 млн
1,27 млд
871,01 млн
Cost of revenue
877,48 млн
792,37 млн
1,27 млд
871,01 млн
Research and development expenses
49,67 млн
80,57 млн
43,07 млн
63,30 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
953,93 млн
942,25 млн
2,92 млд
1,07 млд
Operating expense
2,66 млд
2,64 млд
2,28 млд
2,84 млд
Total operating expenses
3,53 млд
3,43 млд
3,55 млд
3,71 млд
Operating income
758,17 млн
629,68 млн
701,16 млн
787,90 млн
Other non operating income
8,91 млн
90,16 млн
-64,72 млн
51,02 млн
EBT including unusual items
710,26 млн
571,57 млн
697,63 млн
777,12 млн
EBT excluding unusual items
710,26 млн
662,53 млн
663,07 млн
777,12 млн
Income tax expense
181,36 млн
150,70 млн
188,03 млн
208,29 млн
Effective tax rate
25,53%
26,37%
26,95%
26,80%
Other operating expenses
1,33 млд
1,30 млд
-1,07 млд
1,39 млд
Net income
526,68 млн
413,86 млн
509,03 млн
566,67 млн
Net profit margin
12,27%
10,20%
11,99%
12,59%
Earnings per share
2,53
2,31
2,46
2,73
Interest and investment income
-
-
38,12 млн
-
Interest expense
-56,82 млн
-57,30 млн
-79,33 млн
-61,80 млн
Net interest expenses
-56,82 млн
-57,30 млн
-41,21 млн
-61,80 млн
Depreciation and amortization charges
324,08 млн
318,78 млн
385,90 млн
324,03 млн
EBITDA
1,07 млд
680,74 млн
774,79 млн
861,53 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору